Back

Long-term outcomes

31 August 2019 (15:35 - 15:50)
Organised by:
Congress Presentation Part of: What is the long term impact of atrial fibrillation? Insights from GARFIELD-AF Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Dan Atar

Oslo University Hospital Ulleval, Oslo (Norway)

6 More presentations in this session

Presentation thumbnail
What have registries taught us? New insights from GARFIELD-AF
Professor A. Kakkar (London, GB)
Slides Video
Presentation thumbnail
Innovations in risk assessment: an integrated risk tool for stroke, death and bleeding
Professor K. Fox (Edinburgh, GB)
Slides Video
Presentation thumbnail
Changes in antithrombotic therapy after atrial fibrillation diagnosis
Doctor F. Cools (Brasschaat, BE)
Slides Video
Presentation thumbnail
Management of care in atrial fibrillation patients: impact of following guidelines for treatment of atrial fibrillation and comorbid conditions
Professor J. Camm (London, GB)
Slides Video
Presentation thumbnail
Three-way comparison of effectiveness among different classes of oral anticoagulants: GARFIELD-AF study
Professor S. Goto (Isehara, JP)
Slides Video

Access the full session

Session thumbnail
What is the long term impact of atrial fibrillation? Insights from GARFIELD-AF

The Event

Event poster

ESC Congress 2019

31 August 2019 15:35 CET
You may be interested in
thumbnail
Webinar
ESC Guidelines on Acute Pulmonary Embolism ? practical guidance into clinical practice. Part 2: challenges of managing PE in the long term
11 March 2021
thumbnail
Congress Presentation
Long-term clinical outcomes of patients with chronic total coronary occlusion caused by intra-stent re-stenosis
27 August 2021
thumbnail
Congress Presentation
Long-term outcomes in newly diagnosed pulmonary arterial hypertension (PAH) patients receiving initial triple oral combination therapy: Insights from the randomised controlled TRITON study
29 August 2020
thumbnail
Congress Presentation
Association between thromboembolic and bleeding risk with adverse outcomes in contemporary European atrial fibrillation patients: final analysis from the ESC-EHRA EORP AF general long-term registry
23 April 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources